SPDR S&P China ETF (NYSEARCA:GXC) Holdings Boosted by Optimum Investment Advisors

Optimum Investment Advisors boosted its holdings in SPDR S&P China ETF (NYSEARCA:GXC) by 20.9% during the first quarter, HoldingsChannel.com reports. The fund owned 1,542 shares of the company’s stock after acquiring an additional 267 shares during the period. Optimum Investment Advisors’ holdings in SPDR S&P China ETF were worth $101,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Parallel Advisors LLC raised its holdings in shares of SPDR S&P China ETF by 92.2% during the fourth quarter. Parallel Advisors LLC now owns 2,728 shares of the company’s stock valued at $186,000 after buying an additional 1,309 shares during the last quarter. Upper Left Wealth Management LLC acquired a new position in shares of SPDR S&P China ETF during the fourth quarter valued at approximately $239,000. Trexquant Investment LP acquired a new position in shares of SPDR S&P China ETF during the fourth quarter valued at approximately $239,000. Mather Group LLC. acquired a new position in shares of SPDR S&P China ETF during the fourth quarter valued at approximately $242,000. Finally, MONECO Advisors LLC acquired a new position in shares of SPDR S&P China ETF during the fourth quarter valued at approximately $298,000.

SPDR S&P China ETF Price Performance

NYSEARCA GXC opened at $70.53 on Friday. SPDR S&P China ETF has a 12 month low of $59.45 and a 12 month high of $81.72. The firm has a market capitalization of $469.02 million, a PE ratio of 9.52 and a beta of 0.84. The company’s 50 day simple moving average is $71.44 and its 200 day simple moving average is $67.33.

SPDR S&P China ETF Profile

SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors.